{"date":"2025-07-25","count":37,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3705-2025-07-25-2018-bhc8t0","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"20:18:48","subject":"公告本公司增加持有被控股公司家數","clause":"第41款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 20:18，「公告本公司增加持有被控股公司家數」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-25-2018-ms9o2a","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"20:18:29","subject":"代重要子公司永信藥品工業股份有限公司公告因分割減資辦理資本變更登記完成","clause":"第36款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 20:18，「代重要子公司永信藥品工業股份有限公司公告因分割減資辦理資本變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-07-25-1956-1nb1bgk","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"19:56:27","subject":"本公司受邀參加富邦綜合證券舉辦之興櫃前法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-07-25 19:56，「本公司受邀參加富邦綜合證券舉辦之興櫃前法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2025-07-25-1952-1surenn","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"19:52:40","subject":"公告本公司114年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2025-07-25 19:52，「公告本公司114年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-07-25-1950-1e4a96d","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"19:50:13","subject":"公告與越南VGCT簽訂總經銷合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-07-25 19:50，「公告與越南VGCT簽訂總經銷合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-07-25-1838-brhqql","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"18:38:08","subject":"本公司自主開發治療巴金森氏症口服新藥(ENERGI-F705PD)一期臨床試驗達標","clause":"第10款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-07-25 18:38，「本公司自主開發治療巴金森氏症口服新藥(ENERGI-F705PD)一期臨床試驗達標」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1800-4rij4","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"18:00:14","subject":"公告本公司董事會決議通過委任第二屆薪資報酬委員會成員","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 18:00，「公告本公司董事會決議通過委任第二屆薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1759-miw649","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"17:59:26","subject":"公告本公司設置審計委員會及第一屆委員名單","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 17:59，「公告本公司設置審計委員會及第一屆委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1758-s0kpz3","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"17:58:41","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 17:58，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1758-16zk9xb","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"17:58:01","subject":"114年第一次股東臨時會全面改選董事暨董事變動達三分之一","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 17:58，「114年第一次股東臨時會全面改選董事暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1750-1gxtyig","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"17:50:34","subject":"公告本公司114年第一次股東臨時會通過解除新任董事競業禁止之限制","clause":"第22款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 17:50，「公告本公司114年第一次股東臨時會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-07-25-1748-15pbcwo","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"17:48:09","subject":"公告本公司委任第二屆永續發展委員會委員","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-07-25 17:48，「公告本公司委任第二屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-07-25-1748-ub84r7","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-07-25","time":"17:48:00","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-07-25 17:48，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-07-25-1746-1pye8tr","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"17:46:54","subject":"公告本公司委任第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-07-25 17:46，「公告本公司委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-07-25-1745-1k13klw","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"17:45:48","subject":"公告本公司董事會通過114年第2季個別財務報告","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-07-25 17:45，「公告本公司董事會通過114年第2季個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-07-25-1652-1ljqcbg","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:52:34","subject":"公告本公司董事會決議第七次買回庫藏股","clause":"第35款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-07-25 16:52，「公告本公司董事會決議第七次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-07-25-1651-8gmoar","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:51:01","subject":"公告本公司董事會決議解除董事暨經理人競業禁止之限制","clause":"第21款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-07-25 16:51，「公告本公司董事會決議解除董事暨經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-07-25-1649-3bed5x","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:49:59","subject":"公告本公司財務主管暨會計主管異動","clause":"第8款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-07-25 16:49，「公告本公司財務主管暨會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-07-25-1649-1ryuuvm","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:49:51","subject":"公告本公司董事長訂定除權基準日相關事宜","clause":"第14款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-07-25 16:49，「公告本公司董事長訂定除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-07-25-1648-aa2zln","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:48:45","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-07-25 16:48，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-07-25-1620-ft9ck7","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"16:20:58","subject":"公告本公司114年第二季合併財務報告董事會預計召開日期為114年8月4日","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-07-25 16:20，「公告本公司114年第二季合併財務報告董事會預計召開日期為114年8月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2025-07-25-1612-87qz4w","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"16:12:55","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：南光（1752），2025-07-25 16:12，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-07-25-1530-3s4whn","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"15:30:15","subject":"公告本公司114年度第二季合併財務報告董事會預計召開日期為114年8月4日","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-07-25 15:30，「公告本公司114年度第二季合併財務報告董事會預計召開日期為114年8月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-07-25-1515-1yvm1w","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"15:15:44","subject":"公告本公司國內第三次無擔保轉換公司債收足應募價款","clause":"第53款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-07-25 15:15，「公告本公司國內第三次無擔保轉換公司債收足應募價款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2025-07-25-1500-87qz4w","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"15:00:35","subject":"公告本公司114年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永日（4102），2025-07-25 15:00，「公告本公司114年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-25-1439-179rsib","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:39:45","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告董事會選任董事長","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 14:39，「代子公司CARLSBAD TECHNOLOGY, INC.公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-25-1439-192ji85","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:39:25","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告2024年度現金股利配發基準日","clause":"第14款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 14:39，「代子公司CARLSBAD TECHNOLOGY, INC.公告2024年度現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-25-1439-1qv6l67","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:39:02","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告2025年股東常會改選董事","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 14:39，「代子公司CARLSBAD TECHNOLOGY, INC.公告2025年股東常會改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-25-1438-118sbcl","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:38:36","subject":"代子公司CARLSBAD TECHNOLOGY,INC.公告股東會重要決議事項","clause":"第18款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-25 14:38，「代子公司CARLSBAD TECHNOLOGY,INC.公告股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-07-25-1434-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:34:41","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-07-25 14:34，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-07-25-1434-12crnbz","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"14:34:33","subject":"公告本公司董事長決定現金股利除息基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-07-25 14:34，「公告本公司董事長決定現金股利除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-07-25-1434-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:34:07","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-07-25 14:34，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-07-25-1421-1tkkj4d","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"14:21:12","subject":"公告本公司114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-07-25 14:21，「公告本公司114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2025-07-25-1419-9uwwe4","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2025-07-25","time":"14:19:19","subject":"公告114年第2季財務報告董事會預計召開日期為114年8月4日","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2025-07-25 14:19，「公告114年第2季財務報告董事會預計召開日期為114年8月4日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-07-25-1415-arpgp8","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:15:54","subject":"公告本公司董事會決議委任薪資報酬委員會成員","clause":"第6款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-07-25 14:15，「公告本公司董事會決議委任薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-07-25-1412-1okf53h","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"14:12:10","subject":"公告本公司民國114年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-07-25 14:12，「公告本公司民國114年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-07-25-1014-5ckvw2","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-07-25","time":"10:14:06","subject":"依臺灣證券交易所指示澄清媒體報導","clause":"第51款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-07-25 10:14，「依臺灣證券交易所指示澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}